National Second Covishield Dose Can Be Given Between 8-16 Weeks After First Dose, Says NTAGI Reducing Gap BY Outlook Web Desk
National Covishield And Covaxin Get Regular Market Approval For Use In Adult Population BY Outlook Web Desk
National Regular Market Approval Likely To Cap Covishield, Covaxin Price At Rs 275 BY Outlook Web Desk
National NEWSFLASH: Govt Expert Panel Recommends Regular Market Approval For Covishield And Covaxin BY Outlook Web Desk
miscellaneous Mix & Match Of Covaxin, Covishield Elicits 4 Times Antibody Response, Says Study BY Outlook Web Desk
miscellaneous Centre should allow vaccination of children in 12-15 age group: Maha health minister BY Outlook Web Desk
miscellaneous Second COVID-19 Vaccine Dose Of 18 Lakh People Overdue In West Bengal BY Outlook Web Desk
National Covishield Gets Poland's Recognition, Exemption From Quarantine Granted For Those Who Take It BY Outlook Web Desk
National 100 Crore Shots: How India Achieved Covid-19 Vaccination Milestone In 280 Days BY Outlook Web Desk
Making A Difference Countries On Vaccine Eligibility List Under 'Constant Review', Say UK Govt Sources After India’s Reciprocal Action BY Outlook Web Desk
National Covishield Gets Australian Medicine Regulator's Approval For Incoming Travellers BY Outlook Web Desk
National Centre To Receive 20 Crores Of Covishield Doses From Serum Institute In September BY Outlook Web Desk
National Over 3.86 Crore People Yet To Get Complete Vaccination Within Stipulated Time: Govt BY Outlook Web Desk
National Centre Allows Kerala Govt Firm To Purchase 10 Lakh Covishield Doses From Private Sector Quota BY Outlook Web Bureau
National Mixing Covaxin and Covishield: India's Drug Authority Gives Nod To Study, Trials BY Outlook Web Desk
National Combination Of Covishield, Covaxin Better Than 2 Doses Of Same Vaccine: ICMR Study BY Outlook Web Bureau
National Revised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health Minister BY Outlook Web Desk
National Covid-19: Delhi Govt Reserves 40% Covaxin Stock And 20% Covishield Jabs For 1st Shot BY Outlook Web Bureau